| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/08/2007 | WO2007015805A1 1-amino linked compounds |
| 02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 02/08/2007 | US20070032475 Novel compounds useful for bradykinin B1 receptor antagonism |
| 02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
| 02/07/2007 | EP1749005A1 Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | CN1910149A Bronchorelaxing compounds |
| 02/07/2007 | CN1298758C Compositions for producing aminoplast products and method for producing products from these compositions |
| 02/06/2007 | US7173059 Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/01/2007 | WO2007014263A2 Octahydroisoquinoline compounds as opioid receptor modulators |
| 02/01/2007 | WO2007012422A1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | US20070027182 e.g. N-(4a-(3-Methoxyphenyl)-8a-methyl-2-(3-phenylpropyl)octahydroisoquinolin-6-yl]-3-piperidin-1-yl-propionamide; opioid receptor antagonist; analgesic, antidepressant; nervous system disorder; drug abuse, obesity |
| 02/01/2007 | US20070027177 11-(3-fluorophenyl)-9-methoxy-3,4-dihydro-2H-pyrido[1,2-b]isoquinoline-1,6-dione, used as antiarrhythmia agents |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 02/01/2007 | CA2616373A1 Octahydroisoquinoline compounds as opioid receptor modulators |
| 02/01/2007 | CA2615663A1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 01/31/2007 | EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/30/2007 | US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169744 Cleaning compounds; washing, rinsing fabrics, surfaces |
| 01/25/2007 | WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| 01/25/2007 | WO2006098855A3 Processes for preparing morphinans and intermediates thereof |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/24/2007 | EP1745024A1 1-aryl-4-substituted isoquinolines |
| 01/24/2007 | CN1902322A Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/23/2007 | US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166368 A platinum complexes containing a 2,4-pentanedionate group and pyridyl group, maxima spectral emittance |
| 01/18/2007 | WO2007008926A1 Isoquinoline compounds |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015799 Glyoxalase inhibitors |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742919A2 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
| 01/17/2007 | EP1742915A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 01/17/2007 | CN1896065A 1-(3', 4', 5'-tribasic-phenyl)-isoquinoline compound, its preparation and use |
| 01/17/2007 | CN1896064A Metabolites of ecteinascidin 743 |
| 01/16/2007 | US7163949 for the treatment of various neurological and psychological disorders; compounds which block reuptake of norephinephrine, dopamine, and serotonin with particular selectivity ratios; reduced side effect profile |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739073A1 New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/03/2007 | CN1887873A Prepn of 5-iodo-N-[2-(6,7-dimethoxyl-1,2,3,4-tetrahydro isoquinoline)-2-ethyl]methoxyl-benzamide |
| 01/03/2007 | CN1887872A Tetrahydro isoquinoline derivative and its prepn process and medicine use |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | CA2412170C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1222924B1 Anticancer agents |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153809 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 12/21/2006 | WO2006134612A1 A process for the preparation of saquinavir using novel intermediate |
| 12/21/2006 | WO2006134143A1 Process of producing bleach boosters |
| 12/21/2006 | WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 12/21/2006 | WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 12/21/2006 | CA2612279A1 Process of producing bleach boosters |
| 12/21/2006 | CA2611480A1 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| 12/21/2006 | CA2611428A1 Process of producing bleach boosters |
| 12/20/2006 | EP1732898A1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 12/20/2006 | EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 12/20/2006 | EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 12/20/2006 | CN1290500C Retroviral protease inhibitor combinations |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |